Are you experiencing an early pregnancy loss?

You may be eligible to participate in a clinical study.

  

Conceptra Biosciences, along with Tidewater Clinical Research, is currently conducting a study to measure the effectiveness of a medication taken by mouth compared to expectant management for resolution of first trimester pregnancy loss. Expectant management is sometimes called “watchful waiting,” and is considered an alternative to taking a medication or having a procedure. If you’ve been told by a health care provider that you are experiencing a pregnancy loss, they may have used the terms “miscarriage,” “pregnancy loss,” “embryonic demise” or “anembryonic pregnancy.”

image-795190-24.jpg

To be eligible for the study, you must: 


  • Be between the ages of 18 and 50.
  • Be able to provide informed consent.
  • Have little or no vaginal bleeding.
  • Have been pregnant for 10 weeks or less – although you may not know the duration in the case of an anembryonic pregnancy.
  • Have your pregnancy loss confirmed by ultrasound.
Please contact us by completing the form below. Our staff will reach out to you.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.